Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 753 | 301 | 517 | 0 | 0 |
| Cost of Goods | 260 | 213 | 147 | N/A | N/A |
| Gross Profit | 493 | 88 | 370 | N/A | N/A |
| Operating Expenses | 25,143 | 30,028 | 23,701 | 28,088 | 30,233 |
| Operating Income | -24,390 | -29,727 | -23,184 | -28,088 | -30,233 |
| Interest Expense | 2,612 | 2,545 | 3,000 | 2,508 | 2,438 |
| Other Income | 9,492 | -5,386 | 65,323 | 9,656 | -6,531 |
| Pre-tax Income | -17,510 | -37,658 | 39,139 | -20,940 | -39,202 |
| Net Income Continuous | -17,510 | -37,658 | 39,139 | -20,940 | -39,202 |
| Net Income | $-17,510 | $-37,658 | $39,139 | $-20,940 | $-39,202 |
| EPS Basic Total Ops | -0.11 | -0.24 | 0.28 | -0.16 | -0.33 |
| EPS Basic Continuous Ops | -0.11 | -0.24 | 0.30 | -0.16 | -0.33 |
| EPS Diluted Total Ops | -0.11 | -0.24 | 0.28 | -0.16 | -0.33 |
| EPS Diluted Continuous Ops | -0.11 | -0.24 | 0.30 | -0.16 | -0.33 |
| EPS Diluted Before Non-Recurring Items | -0.14 | -0.24 | -0.10 | -0.16 | -0.33 |
| EBITDA(a) | $-22,525 | $-27,867 | $-21,352 | $-26,280 | $-28,421 |